インターヴェンショナル腫瘍学の世界市場2017-2021

【英語タイトル】Global Interventional Oncology Market 2017-2021

Technavioが出版した調査資料(IRTNTR12231)・商品コード:IRTNTR12231
・発行会社(調査会社):Technavio
・発行日:2017年3月13日
・ページ数:70
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥504,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、インターヴェンショナル腫瘍学の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、インターヴェンショナル腫瘍学の世界市場規模及び予測、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Interventional Oncology
Interventional oncology procedures involve the diagnosis and treatment of cancer and cancer-related problems by using minimally invasive (MI) procedures performed under image guidance. Interventional oncology uses X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to guide accessories and instruments, such as ablation electrodes, biopsy needles, guidewires, and intravascular catheters that allow the treatment of a tumor located in some part of the body. Interventional oncology treatments are regularly carried out by interventional radiologists with appropriate settings and facilities. Interventional oncology is used to treat primary or metastatic cancer, which includes liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, and prostate and pancreatic cancer.

Technavio’s analysts forecast the global interventional oncology market to grow at a CAGR of 11.17% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global interventional oncology market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of interventional oncology.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Interventional Oncology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BTG
• Boston Scientific
• Medtronic
• Merit Medical
• TERUMO CORPORATION

[Other prominent vendors]
• Accuray
• ALPINION MEDICAL SYSTEMS
• AngioDynamics
• AtriCure
• Baylis Medical
• BOVIE MEDICAL
• Brainlab
• BSD Medical Corporation
• C. R. Bard
• C2 Therapeutics
• CardioFocus
• Cook Medical
• Eckert and Ziegler BEBIG
• EDAP TMS
• Elekta
• Galil Medical
• HealthTronics
• INSIGHTEC
• MedWaves
• Mermaid Medical
• Microsulis Medical
• Monteris Medical
• NeuWave Medical
• Perseon
• Profound Medical
• Sirtex
• Smith & Nephew
• SonaCare Medical
• Varian Medical

[Market driver]
• Growing demand for MI procedures
• For a full, detailed list, view our report

[Market challenge]
• Risks associated with interventional oncology procedures
• For a full, detailed list, view our report

[Market trend]
• Growing integration of image-guided solutions with interventional oncology procedures
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Five force analysis

PART 06: Market segmentation by procedure
• Ablation
• Global interventional oncology ablation market
• Embolization
• Global interventional oncology embolization market

PART 07: Geographical segmentation
• Interventional oncology market in Americas
• Interventional oncology market in EMEA
• Interventional oncology market in APAC

PART 08: Market drivers
• Growing cancer population
• Growing R&D activities
• Advances in technology
• Growing demand for MI procedures

PART 09: Impact of drivers

PART 10: Market challenges
• Risks associated with interventional oncology procedures
• High cost of interventional oncology procedures
• Presence of alternatives
• Limited skilled practitioners

PART 11: Impact of drivers and challenges

PART 12: Market trends
• Growing integration of image-guided solutions with interventional oncology procedures
• Increasing inorganic growth strategies by vendors
• Growing focus toward the adoption of MWA
• Growing adoption of SIRT and HIFU
• Competitive scenario

PART 13: Vendor landscape
• Key news
• Mergers and acquisitions

PART 14: Key vendor analysis
• Boston Scientific
• BTG
• Medtronic
• Merit Medical
• TERUMO CORPORATION
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]  
Exhibit 01: Product offerings
Exhibit 02: Key highlights of interventional oncology market
Exhibit 03: Snapshot of global interventional oncology market
Exhibit 04: Global interventional oncology market 2016-2021 ($ millions)
Exhibit 05: Interventional oncology market: Opportunity assessment
Exhibit 06: Five forces analysis
Exhibit 07: Global interventional oncology market segmentation by procedure
Exhibit 08: Global interventional oncology market segmentation by procedure 2016 and 2021
Exhibit 09: Global interventional oncology market segmentation by procedure 2016
Exhibit 10: Global interventional oncology market segmentation by procedure 2016: Lifecycle analysis
Exhibit 11: Global interventional oncology ablation market: Snapshot
Exhibit 12: Global interventional oncology ablation market 2016-2021 ($ millions)
Exhibit 13: Global interventional oncology embolization market: Snapshot
Exhibit 14: Global interventional oncology embolization market 2016-2021 ($ millions)
Exhibit 15: Global interventional oncology market segmentation by procedure 2016-2021 ($ millions)
Exhibit 16: Global interventional oncology market segmentation by procedure type 2016-2021 (%)
Exhibit 17: Global interventional oncology market segmentation by geography 2016 and 2021
Exhibit 18: Global interventional oncology market: Geographical presence
Exhibit 19: Global interventional oncology market segmentation by geography 2016
Exhibit 20: Global interventional oncology market segmentation by geography 2016: Lifecycle analysis
Exhibit 21: Interventional oncology market in Americas 2016-2021 ($ millions)
Exhibit 22: Market overview: Americas
Exhibit 23: Interventional oncology market in EMEA 2016-2021 ($ millions)
Exhibit 24: Market overview: EMEA
Exhibit 25: Interventional oncology market in APAC 2016-2021 ($ millions)
Exhibit 26: Market overview: APAC
Exhibit 27: Global interventional oncology market segmentation by geography 2016-2021 ($ millions)
Exhibit 28: Global interventional oncology market segmentation by geography 2016-2021
Exhibit 29: Impact of drivers
Exhibit 30: Complications associated with interventional oncology procedures
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Major M&A in global interventional oncology market
Exhibit 33: Comparison of MWA over RFA methods
Exhibit 34: Competitive structure analysis of global interventional oncology market 2016
Exhibit 35: Market share analysis of vendors in interventional oncology market 2016
Exhibit 36: Competitive landscape analysis of global interventional oncology market 2016
Exhibit 37: Strategic success factors of companies in global interventional oncology market
Exhibit 38: Boston Scientific: Key highlights
Exhibit 39: Boston Scientific: Strength assessment
Exhibit 40: Boston Scientific: Strategy assessment
Exhibit 41: Boston Scientific: Opportunity assessment
Exhibit 42: BTG: Key highlights
Exhibit 43: BTG: Strength assessment
Exhibit 44: BTG: Strategy assessment
Exhibit 45: BTG: Opportunity assessment
Exhibit 46: Medtronic: Key highlights
Exhibit 47: Medtronic: Strength assessment
Exhibit 48: Medtronic: Strategy assessment
Exhibit 49: Medtronic: Opportunity assessment
Exhibit 50: Merit Medical: Key highlights
Exhibit 51: Merit Medical: Strength assessment
Exhibit 52: Merit Medical: Strategy assessment
Exhibit 53: Merit Medical: Opportunity assessment
Exhibit 54: TERUMO CORPORATION: Key highlights
Exhibit 55: TERUMO CORPORATION: Strength assessment
Exhibit 56: TERUMO CORPORATION: Strategy assessment
Exhibit 57: TERUMO CORPORATION: Opportunity assessment



【掲載企業】

BTG, Boston Scientific, Medtronic, Merit Medical, TERUMO CORPORATION, Accuray, ALPINION MEDICAL SYSTEMS , AngioDynamics, AtriCure, Baylis Medical, BOVIE MEDICAL, Brainlab, BSD Medical Corporation, C. R. Bard, C2 Therapeutics, CardioFocus, Cook Medical, Eckert and Ziegler BEBIG, EDAP TMS, Elekta, Galil Medical, HealthTronics, INSIGHTEC, MedWaves, Mermaid Medical, Microsulis Medical, Monteris Medical, NeuWave Medical, Perseon, Profound Medical, Sirtex , Smith & Nephew, SonaCare Medical, and Varian Medical

【レポートのキーワード】

インターヴェンショナル腫瘍学、インターヴェンショナルオンコロジー、腫瘍アブレーション、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[インターヴェンショナル腫瘍学の世界市場2017-2021] (コード:IRTNTR12231)販売に関する免責事項を必ずご確認ください。
★調査レポート[インターヴェンショナル腫瘍学の世界市場2017-2021]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆